Polynovo (ASX:PNV) To Launch Novosorb BTM In Taiwan. | Kalkine Market Update AUS |

  • October 28, 2020 02:04 PM AEDT
  • Team Kalkine
    Team Kalkine
    admin Team Kalkine
    16932 Posts

    Team Kalkine comprises of experts who understand various markets nuances and are enthusiastic and passionate to provide best possible offerings in the form of insights and stories. The team has rich experience of working across different markets with...

PolyNovo (ASX: PNV) has acquired Taiwanese Food and Drug Administration (FDA) approval for the company’s dermal scaffolding product. The company said it has also made a contract with Evermed, a Taiwan-based distributor to sell BTM. PolyNovo Managing Director Paul Brennan commented that the approval is an exciting development for PolyNovo.

King River Resources Commences Drilling at Mt Remarkable Gold Project, Stock Up ~7%

The stock of Australian explorer King River Resources Limited (ASX: KRR) traded higher by 6.896 percent to $0.031 on 28 October 2020 (AEST 1:37 PM). The Company aiming towards testing for high-grade gold mineralization has commenced a 2,500m RC drill program at Western Australia-based Mt Remarkable Project.

* CLINUVEL’s (CUV) Afamelanotide To Be Used In Acute Stroke Patients

ASX 200 listed company CLINUVEL PHARMACEUTICALS LIMITED’s (ASX: CUV) drug afamelanotide shall be used in patients suffering from acute stroke. The study will assess the safety as well as the efficacy of afamelanotide in arterial ischaemic stroke (AIS).

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK